FDA Panel Recommends Pulling Preterm Birth Drug From the Marketnews2022-10-19T19:50:02+00:00October 19th, 2022|The New York Times|
Biden Tries to Reassure Voters on Health Care Costs Before Electionnews2022-10-15T01:03:45+00:00October 15th, 2022|The New York Times|
What A.L.S. and Alzheimer’s Drug Approvals Have in Commonnews2022-10-14T19:10:06+00:00October 14th, 2022|The New York Times|
F.D.A. Confirms Widespread Shortages of Adderallnews2022-10-13T18:04:42+00:00October 13th, 2022|The New York Times|
¿Las nuevas vacunas contra la malaria podrán erradicarla?news2022-10-08T09:00:27+00:00October 8th, 2022|The New York Times|
Can New Vaccines Finally Eradicate Malaria?news2022-10-04T10:12:35+00:00October 4th, 2022|The New York Times|
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Saysnews2022-09-30T20:16:18+00:00September 30th, 2022|The New York Times|
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
FDA Approves ALS Treatment Despite Questions About Effectivenessnews2022-09-29T21:14:36+00:00September 29th, 2022|The New York Times|
Alzheimer’s Drug Slows Cognitive Decline in Key Studynews2022-09-28T13:42:59+00:00September 28th, 2022|The New York Times|
